| Literature DB >> 32677512 |
Nicholas Hui1,2, Kevin Phan1,2, Mei-Yi Lee1,3, Jack Kerferd1,2, Telvinderjit Singh1,2, Ralph J Mobbs1,2,4.
Abstract
STUDYEntities:
Keywords: arthroplasty; biomechanics; cervical spine; heterotopic ossification
Year: 2020 PMID: 32677512 PMCID: PMC8119929 DOI: 10.1177/2192568220922949
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.PRISMA 2009 flow diagram.
Study Characteristics.a
| Study | Follow-up Duration (year) | Study Design | Prosthesis | HO Prevalence (%) | Mean Age (years) | Male (%) | Single-Level CTDR (%) | C4/C5 (%) | C5/C6 (%) | C6/C7 (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Gao et al,[ | 5.35 | Observational study | Prestige LP | 16.7 | 45.4 | 62.5 | 0 | / | 50.0 | 15.4 |
| Pointillart et al,[ | 15.5 | Observational study | Bryan | 54.5 | 46.2 | 55.6 | 77.8 | 9.1 | 50.0 | 40.9 |
| Zeng et al,[ | 6.78 | Observational study | Prestige LP | 46.7 | 43.8 | 42.2 | 100 | 6.7 | 51.1 | 40.0 |
| Wu et al,[ | 2.68 | Observational study | Prestige LP | 4.0 | 44.8 | 48.0 | 0 | / | 36.0 | 12.0 |
| Chang et al,[ | 2.31 | Observational study | Prestige LP | 87.5 | 45.6 | 42.0 | 100 | 14.0 | 72.0 | 4.0 |
| Wu et al,[ | 2.51 | Observational study | Prestige LP, Zero-P | 7.4 | 48.1 | 59.3 | 0 | / | / | / |
| Heo et al,[ | 2.69 | Observational study | Baguera-C | 29.2 | 50.7 | 37.5 | 100 | 12.5 | 68.8 | 16.7 |
| Tian et al,[ | 6.71 | Observational study | Bryan | 2.7 | 45.0 | 67.9 | 71.4 | 21.6 | 59.5 | 13.5 |
| Lei et al,[ | 8.75 | Observational study | Bryan | 51.4 | 42.6 | 48.4 | 87.1 | 16.1 | 32.3 | 35.5 |
| Shichang et al,[ | 3.84 | Observational study | Prestige LP | 28.2 | 46.3 | 43.5 | 100 | 38.8 | 44.7 | 7.1 |
| Zhao et al,[ | 10.04 | Observational study | Bryan | 69.0 | 44.8 | 57.6 | 75.8 | 16.7 | 61.9 | 14.3 |
| Qizhi et al,[ | 2.7 | RCT | Discover | 0 | 46.8 | 64.3 | 0 | 21.4 | 28.6 | 21.4 |
| Fransen et al,[ | 2 | Observational study | Baguera-C | 53.2 | / | / | 60.6 | 15.4 | 43.1 | 38.2 |
| Shi et al,[ | 2 | Observational study | Discover | 13.3 | 46.5 | 40.0 | 100 | 33.3 | 41.7 | 16.7 |
| Kim et al,[ | 5.01 | Observational study | Bryan | 18.9 | 45.4 | 64.9 | 100 | 13.5 | 64.9 | 16.2 |
| Lee et al,[ | 3.61 | Observational study | Mobi-C | 78.6 | 47.1 | 85.7 | 100 | 21.4 | 35.7 | 42.9 |
| Zhang et al,[ | 2 | Observational study | Bryan, ProDisc-C | 34.0 | 42.7 | 50.9 | 100 | / | / | / |
| Ding et al,[ | 2.81 | Observational study | Mobi-C | 7.7 | 50.6 | 61.5 | 0 | / | / | / |
| Qi et al,[ | 2.2 | Observational study | Discover | 27.9 | 43.1 | 54.4 | 76.8 | 27.2 | 33.6 | 7.2 |
| Zhao et al,[ | 5.25 | Observational study | ProDisc-C | 65.4 | 44.0 | 61.5 | 100 | 15.4 | 61.5 | 11.5 |
| Li et al,[ | 2 | Observational study | Discover | 18.2 | 46.4 | 49.1 | 100 | 20.0 | 61.8 | 10.9 |
| Chen et al,[ | 2 | Observational study | Prestige LP | 16.1 | 45.0 | 58.1 | 100 | 6.5 | 90.3 | 0 |
| Chung et al,[ | 1.5 | Observational study | Bryan | 68.4 | 50.1 | 63.2 | 100 | 5.3 | 47.4 | 47.4 |
| Guérin et al,[ | 1.75 | Observational study | Mobi-C | 27.7 | 41.2 | 45.1 | 77.5 | / | / | / |
| Barrey et al,[ | 3.13 | Observational study | Discover | 18.8 | 42.3 | 43.8 | 100 | 3.1 | 75.0 | 21.9 |
| US FDA IDE trial (P100003)[ | 2 | RCT | Secure-C | 74.2 | 42.7 | 53.3 | 100 | 6.3 | 51.3 | 39.2 |
| Wang et al,[ | 2 | Observational study | Bryan | 0 | 46.5 | 65.0 | 85.0 | 30.4 | 52.2 | 0 |
| Du et al,[ | 1.275 | Observational study | Discover | 0 | 47.9 | 56.0 | 96.0 | / | / | / |
| Cardoso et al,[ | 1.5 | Observational study | Prestige ST | 0 | 50.0 | 58.1 | 0 | 23.3 | 60.0 | 6.7 |
| Kowalczyk et al,[ | 1 | Observational study | Bryan, ProDisc-C, Prestige LP | 3.3 | 44.4 | 50.0 | 100 | 8.3 | 55.0 | 33.3 |
| Walraevens et al,[ | 8 | Observational study | Bryan | 38.5 | 42.8 | 42.7 | 100 | / | / | / |
| Lee et al,[ | 1.17 | Observational study | Bryan, Prestige | 27.1 | 44.0 | 56.3 | 100 | 12.5 | 56.3 | 29.2 |
| Ryu et al,[ | 2.275 | Observational study | Bryan, ProDisc-C | 52.8 | 46.6 | 58.3 | 100 | 19.4 | 47.2 | 30.6 |
| Yang et al,[ | 2.46 | Observational study | Bryan | 0 | 45.4 | 66.7 | 100 | 31.3 | 37.5 | 12.5 |
| Kim et al,[ | 2 | Observational study | Bryan | 0 | / | 63.8 | 83.0 | 16.4 | 47.3 | 36.4 |
Abbreviations: HO, Heterotopic Ossification; CTDR, Cervical Total Disc Replacement; RCT, Randomized Controlled Trial.
a / = data not available.
Figure 2.aRisk of bias summary table.
a ? = unclear risk of bias; + = low risk of bias; − = high risk of bias.
The Biomechanics of the Cervical Spine Before and After CTDR and Their Differences.
| Baseline | Final FU | Difference | ||||
|---|---|---|---|---|---|---|
| Number of Studies ( | Biomechanical Value (95% CI) | Number of Studies ( | Biomechanical Value (95% CI) | Number of Studies ( | Biomechanical Value (95% CI) | |
| ROM lower | 13 (98.2%) | 6.33 (4.56 to 8.10) | 12 (94.6%) | 9.45 (8.36 to 10.54) | 12 (11.8%) | 0.38 (0.02 to 0.74)a |
| ROM upper | 15 (90.3%) | 9.80 (8.95 to 10.64) | 13 (93.5%) | 10.15 (9.17 to 11.14) | 13 (0%) | 0.43 (0.12 to 0.75)a |
| FSU ROM | 34 (93.2%) | 9.61 (8.98 to 10.23) | 34 (96.9%) | 9.33 (8.51 to 10.14) | 31 (81.1%) | −0.46 (−1.07 to 0.16) |
| Cervical ROM | 14 (92.5%) | 48.77 (45.20 to 52.34) | 14 (97.2%) | 47.54 (42.64 to 52.43) | 13 (82.2%) | −1.41 (−4.66 to 1.84) |
| FSU angle | 12 (95.8%) | 1.82 (0.74 to 2.90) | 10 (96.4%) | 4.06 (2.64 to 5.48) | 10 (87.7%) | 2.23 (1.11 to 3.35)a |
| Cobb angle | 14 (88.6%) | 11.31 (9.43 to 13.20) | 14 (95.6%) | 14.67 (11.93 to 17.40) | 13 (70.4%) | 3.49 (1.73 to 5.25)a |
Abbreviations: FU, follow-up; I2, heterogeneity; ROM, range of motion; FSU, functional spinal unit.
a P < .05.
Subgroup Analysis of the Difference in Biomechanics Stratified by the Length of Follow-up.a
| 1-2 Years | 2-3 Years | 3-4 Years | 4-5 Years | 5-6 Years | >6 Years | ||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Studies ( | Biomechanical Value (95% CI) | Number of Studies ( | Biomechanical Value (95% CI) | Number of Studies ( | Biomechanical Value (95% CI) | ||||
| FSU ROM | 12 (72.1%) | −0.03 (−0.90 to 0.84) | 7 (73.7%) | 0.87 (−0.03 to 1.78) | / | / | / | 6 (0%) | −2.15 (−2.97 to −1.33)b |
| Cobb angle | 5 (0%) | 1.97 (0.91 to 3.04) | 6 (72.0%) | 5.30 (2.30 to 8.29) | / | / | / | / | / |
Abbreviations: I2, heterogeneity; ROM, range of motion; FSU, functional spinal unit.
a Only the cells with number of studies ≥5 are displayed.
b There is no overlap with the CI of studies with 1 to 2 years of follow-up.
Multivariable Metaregression of the Effects of Various Variables on the Changes in Cervical Biomechanics.
| Number of Studies |
| C5/C6 | C6/C7 | HO | Single-Level CTDR | Length of FU | ROM-Limiting HO | |
|---|---|---|---|---|---|---|---|---|
| ROM lower segment | 12 | 60.4% | / | / | 0.61 | / | / | |
| ROM lower segment | 12 | 10.1% | / | / | 0.71 | / | 0.29 | / |
| ROM lower segment | 11 | 100% | / | / | / | / | 0.26 | |
| ROM lower segment | 9 | NA | 0.61 | / | / | / | / | 0.30 |
| ROM lower segment | 9 | NA | / | 0.88 | / | / | / | 0.59 |
| ROM upper segment | 13 | 0 | / | / | 0.30 | / | 0.16 | / |
| ROM upper segment | 13 | 0 | / | / | 0.65 | 0.66 | / | / |
| ROM upper segment | 12 | 0 | / | / | / | 0.63 | / | 0.90 |
| ROM upper segment | 10 | NA | 0.62 | / | / | / | / | 0.52 |
| ROM upper segment | 10 | NA | 0.37 | / | / | / | / | 0.27 |
| FSU ROM | 31 | 30.1% | / | / | 0.43 | 0.22 | / | |
| FSU ROM | 26 | 30.6% | / | / | / | 0.35 | 0.076 | 0.73 |
| FSU ROM | 23 | 9.4% | 0.058 | 0.17 | / | / | / | 0.75 |
| Cervical ROM | 13 | 35.3% | / | / | 0.96 | / | / | |
| Cervical ROM | 13 | 0 | / | / | 0.64 | / | 0.95 | / |
| Cervical ROM | 13 | 42.6% | / | / | / | / | 0.51 | |
| Cervical ROM | 10 | 0 | 0.21 | / | / | / | / | 0.66 |
| Cervical ROM | 10 | 0 | / | 0.68 | / | / | / | 0.85 |
| FSU angle | 10 | 17.9% | / | / | 0.11 | 0.12 | / | / |
| FSU angle | 10 | 0 | / | / | 0.37 | / | 0.84 | / |
| Cobb angle | 13 | 6.1% | / | / | 0.14 | / | 0.86 | / |
| Cobb angle | 13 | 2.2% | / | / | 0.19 | 0.97 | / | / |
| Cobb angle | 13 | 0 | / | / | / | 0.93 | / | 0.25 |
Abbreviations: I2, heterogeneity; HO, heterotopic ossification; CTDR, cervical total disc replacement; FU, follow-up; ROM, range of motion; FSU, functional spinal unit.